Maiwald Magazine

News and Releases

Maiwald Blog

Quality Dashboard of the EPO – useful for applicants?

A few days ago, the European Patent Office (EPO) started publishing quality indicators on a specially created quality dashboard (see:

Continue reading

The European Patent Office (EPO) has announced that its fees will increase from 1 April 2024

The European Patent Office will increase most of its fees by an average of around 5% as of April 1, 2024. The fee increase will be significantly higher for the 3rd and 4th ren...

Continue reading

European Parliament Supports Use of Some Plants Generated By New Genomic Techniques (NGT) But Opposes Patents for all NGT Plants

In a vote held on 7 February 2024, the European Parliament (EP) approved a proposal to

Continue reading

All articles

Press Coverage

The UPC has become known for its expeditious decision-making processes

The UPC has become known for its expeditious decision-making processes. Just how expeditious it can be, has been shown in a recent case filed with the Munich local division against one of our clients. After a quick review of the claimant’s statement of claim, we infor...

Continue reading

The winners of “Munich’s outstanding companies 2023” award

On November 30, the city honored companies that have shown particularly exemplary commitment to the well-being of Munich residents with the "Munich's outstanding companies" award. We are delighted that we were able to sup...

Continue reading

Maiwald in the press

Staff News

Maiwald appoints Dr. Sun Jin Lee, Sebastian Herzog and Dr. Tobias Philipp as partners

Maiwald is pleased to announce the appointment of Dr. Sun Jin Lee,

Continue reading

Dr Isabel Tomerius joins Maiwald as Partner

Patent attorney Dr Isabel Tomerius joi...

Continue reading

Staff News

Publications

Reliance on a purported technical effect for inventive step – Quo vadis “plausibility” after G 2/21? epi Information, 1/2024

In the context of the effect-driven assessment of inventive step under the European Patent Convention (EPC) it is usually crucial for the outcome whether an Applicant/a Patent...

Continue reading

Wettbewerbsrecht im Kontext von F&E- und Linzenzverträgen, PharmR 3/2024

In the trade journal Pharma Recht (46th year, 15 March 2024), Dr. Marco Stief deals with the competition law assessment of research, cooperation and development agreements, wi...

Continue reading

All publications

Awards

Chambers Europe Guide 2024

Every year, Chambers Europe ranks the top lawyers and law firms across Europe, providing indispensable insights, and market intelligence for law firm clients as well as legal ...

Continue reading

Who is Who Legal 2024

We are delighted that Dr. Marco Stief has once again been recognized in the WWL: Germany 2024 ranking by Who's Who Le...

Continue reading

The Legal 500 Deutschland 2024

Maiwald is recommended in 3 practice areas in the 2024 edition of The Legal 500 Germany. A total of 18 lawyers are mentioned by name in the Legal 500 Germany commentary fo...

Continue reading

All awards

Events

Compact seminar of the Aktion Plagiarius e.V.:
Ich hab ‘ne tolle Idee, und jetzt?
Wie Sie Ihre Ideen erfolgreich umsetzen, vermarkten und schützen (Lecutres held in German)

Well informed, and with courage, perseverance and the right partner at your side to success! Did you know that it is much easier to attract investors if the promising, freshly developed innovation is protected by registered industrial property rights such as trademarks, designs and patents? And did you a...

Continue reading

Deutscher Pharma Recht Tag 2024 in Frankfurt, April 23, 2024

We are pleased to have Dr. Marco Stief give a presentation on ''No-Challenge Clauses in R&D, cooperation, license and settlement agreements'' at the 36th German Pharma Law Day. This is a topic that has grown in relevance and complexity in recent years and whose basic principles should be familiar to anyone involved in R&D, cooperation and license agreements or in I...

Continue reading

We are delighted to be taking part in Girls’ & Boys’ Day on April 25!

The "Girls' Day - Girls' Future Day" project aims to help improve the career opportunities of girls in promising professional fields in which they are currently underrepresented. We are therefore particularly pleased to be able to show the participants a day at Maiwald IT - from software development to system administration.

Continue reading

Meet Maiwald at LSPN North America Spring in Boston (May 8-9, 2024)

We are excited to announce that we are a silver sponsor to the upcoming Life Sciences Patent Network Spring 2024 conference in Boston on May 8-9 - a unique opportunity to network, gain valuable insights into the latest trends, challenges, and best practices shaping the future of life sciences innovation. Don't miss the c...

Continue reading

All events